Kinrix Market Report 2026

Kinrix Market Overview

• The Kinrix market growth in the historic period has been driven by need for efficient pediatric immunization, government supported vaccination programs • Market expansion is supported by expansion of booster dose coverage, increasing school immunization mandates • Growth Driver: Growing Demand For Combination Vaccines Drives Market Expansion • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Kinrix Market?

Kinrix is a combination vaccine that protects against four diseases, namely diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis (polio). It contains diphtheria, tetanus toxoids, acellular pertussis vaccine adsorbed (DTaP), and inactivated poliovirus vaccine (IPV). This vaccine simplifies immunization schedules by reducing the number of separate injections required, ensuring continued protection against these serious diseases conveniently and efficiently. The main indication types of kinrix are vaccination against diphtheria, vaccination against tetanus, vaccination against pertussis, and vaccination against poliomyelitis. Vaccination against diphtheria involves administering a toxoid vaccine to stimulate immunity, preventing severe respiratory infections caused by Corynebacterium diphtheriae. The formulations are injectable formulations and pre-filled syringes, and patient demographics include pediatric and adult. The distribution channels are direct sales, wholesalers and distributors, retail pharmacies, and online pharmacies, and it is used by various end users such as pediatric clinics, hospitals, family practice clinics, and public health departments.

What Is The Kinrix Market Growth Forecast?

The growth in the forecast period can be attributed to expansion of booster dose coverage, increasing school immunization mandates, growth in pediatric healthcare spending, continued preference for combination vaccines, improved vaccine logistics. Major trends in the forecast period include growing adoption of combination pediatric vaccines, simplification of childhood immunization schedules, reduction in multiple injection burden, strengthening of routine booster vaccination programs, integration into school age immunization policies.

Global Kinrix Market Segmentation

1) By Indication: Vaccination Against Diptheria, Vaccination Against Tetanus, Vaccination Against Pertussis, Vaccination Against Poliomyelitis 2) By Formulation: Injectable Formulation, Pre-filled Syringes 3) By Patient Demographics: Pediatric, Adult 4) By Distribution Channel: Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies 5) By End Users: Pediatric Clinics, Hospitals, Family Practice Clinics, Public Health Departments

What Are The Drivers Of The Kinrix Market?

The rise in demand for combination vaccines is expected to propel the growth of kinrix market going forward. A combination vaccine is a single injection that protects against multiple diseases by including antigens for two or more pathogens, thereby reducing the number of shots required for immunization. Demand for combination vaccines is rising due to factors such as enhanced vaccination coverage, lower costs, improved compliance, and reduced number of injections. Kinrix is a combination vaccine used as a booster to protect children aged 4–6 years against diphtheria, tetanus, pertussis, and poliovirus, reducing the number of injections required. For instance, in June 2024, according to Moderna, Inc., a US-based clinical research organization, as of May 2024, adults aged 18 and older in the U.S. received the 2023/2024 influenza vaccine at more than twice the rate of the updated COVID-19 vaccine. Therefore, the rise in demand for combination vaccines drives the kinrix industry. The rise in healthcare expenditure is expected to propel the growth of the kinrix market going forward. Healthcare expenditure includes spending on medical services, infrastructure, pharmaceuticals, and healthcare-related activities. The demand for healthcare services is increasing as more people are seeking preventive care and efficient immunization solutions. Kinrix supports vaccination programs by combining protection against multiple diseases in a single dose, reducing injections, saving time, and improving overall public health outcomes. For instance, in May 2024, according to a report published by the Office for National Statistics, a UK-based government agency, total healthcare expenditure rose by 5.6% in nominal terms from 2022 to 2023, compared to a growth rate of 0.9% in 2022. Additionally, total long-term health and social care expenditure increased by 2.8% in real terms in 2022. Therefore, the increase in healthcare expenditure drives the kinrix industry.

Key Players In The Global Kinrix Market

Major companies operating in the kinrix market are GlaxoSmithKline plc

What Are Latest Mergers And Acquisitions In The Kinrix Market?

In May 2024, GlaxoSmithKline plc a UK-based pharmaceutical company, partnered with the Department of Health, Abu Dhabi (DoH), to establish a regional vaccine distribution hub in Abu Dhabi. This strategic collaboration formalized through a Memorandum of Understanding (MoU), aims to enhance healthcare innovation and improve vaccine accessibility across the region. The Department of Health- Abu Dhabi (DoH) is a UAE-based government healthcare agency focusing on increasing awareness and adoption of healthy living standards among residents in the UAE.

Regional Insights

North America was the largest region in the kinrix market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Kinrix Market?

The kinrix market consists of sales of pre-filled syringes or single-dose vials of kinrix (DTaP-IPV). Values in this market are ‘factory gate’ values, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Kinrix Market Report 2026?

The kinrix market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the kinrix industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.